Guo, Junqing,Hart, Amy C.,Macor, John E.,Mertzman, Michael E.,Pitts, William J.,Spergel, Steven H.,Watterson, Scott Hunter,Andappan Murugaiah Subbaiah, Murugaiah,Chen, Jie,Dzierba, Carolyn Diane,Luo,
申请号：
AU2018217488
公开号：
AU2018217488A1
申请日:
2018.02.12
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
Compounds having formula (I) (IX), and enantiomers, and diastereomers, stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein: (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).
